We have recently shown that, among carriers of CHEK2 mutations, the risk of breast cancer was much greater for women who also carried a specific missense variant in BRCA2 and the interaction was statistically significant (P=0.03; Serrano-Fernández et al, 2008). The gene discussed is BRCA2; the disease is breast carcinoma.